De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Sang-A FrontecLtd Toekomstige groei

Future criteriumcontroles 5/6

Sang-A FrontecLtd is forecast to grow earnings and revenue by 39.4% and 20.3% per annum respectively. EPS is expected to grow by 37.5% per annum. Return on equity is forecast to be 8.6% in 3 years.

Belangrijke informatie

39.4%

Groei van de winst

37.5%

Groei van de winst per aandeel

Electronic winstgroei	30.3%
Inkomstengroei	20.3%
Toekomstig rendement op eigen vermogen	8.6%
Dekking van analisten	Low
Laatst bijgewerkt	29 Aug 2024

Recente toekomstige groei-updates

Recent updates

Is Sang-A FrontecLtd (KOSDAQ:089980) Using Too Much Debt?

Aug 15

With A 25% Price Drop For Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) You'll Still Get What You Pay For

Jul 30

Investors Could Be Concerned With Sang-A FrontecLtd's (KOSDAQ:089980) Returns On Capital

Jun 08

Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) 26% Share Price Surge Not Quite Adding Up

May 07

Is It Time To Consider Buying Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)?

May 02

We Think Sang-A FrontecLtd (KOSDAQ:089980) Is Taking Some Risk With Its Debt

Apr 12

Returns On Capital Signal Tricky Times Ahead For Sang-A FrontecLtd (KOSDAQ:089980)

Apr 13

Estimating The Intrinsic Value Of Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)

Mar 02

These 4 Measures Indicate That Sang-A FrontecLtd (KOSDAQ:089980) Is Using Debt Extensively

Feb 14

Is Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) Potentially Undervalued?

Jan 24

Shareholders Of Sang-A FrontecLtd (KOSDAQ:089980) Must Be Happy With Their 286% Total Return

Jan 05

What Type Of Shareholders Make Up Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) Share Registry?

Dec 21

Should We Be Excited About The Trends Of Returns At Sang-A FrontecLtd (KOSDAQ:089980)?

Dec 03

Winst- en omzetgroeiprognoses

KOSDAQ:A089980 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (KRW Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	282,500	12,300	1,300	30,000	1
12/31/2025	222,100	7,300	600	23,200	1
12/31/2024	188,850	5,250	-23,900	2,500	2
6/30/2024	176,421	7,656	-5,727	33,694	N/A
3/31/2024	180,489	10,997	-11,049	16,242	N/A
12/31/2023	183,599	11,994	-157	28,675	N/A
9/30/2023	187,655	2,599	6,139	35,047	N/A
6/30/2023	189,942	5,873	-1,766	19,587	N/A
3/31/2023	186,974	7,829	-10,327	17,439	N/A
12/31/2022	181,156	7,426	-12,812	15,607	N/A
9/30/2022	180,384	9,911	-19,626	12,847	N/A
6/30/2022	178,998	10,096	-19,556	14,410	N/A
3/31/2022	179,234	8,988	-11,516	20,042	N/A
12/31/2021	178,481	9,299	-19,153	20,857	N/A
9/30/2021	177,457	6,214	-27,779	11,924	N/A
6/30/2021	172,449	2,772	-25,489	7,515	N/A
3/31/2021	159,431	2,248	-9,176	17,664	N/A
12/31/2020	153,347	2,320	-2,204	12,455	N/A
9/30/2020	147,657	4,102	-2,483	10,870	N/A
6/30/2020	151,379	6,701	4,963	16,621	N/A
3/31/2020	169,423	9,471	-10,989	134	N/A
12/31/2019	186,171	12,454	-6,770	3,513	N/A
9/30/2019	199,507	17,380	1,816	6,285	N/A
6/30/2019	202,039	17,597	-1,532	4,030	N/A
3/31/2019	193,009	15,508	-189	7,607	N/A
12/31/2018	182,074	12,064	-3,397	7,468	N/A
9/30/2018	162,300	7,398	-4,675	11,845	N/A
6/30/2018	155,269	6,323	-2,010	14,428	N/A
3/31/2018	155,947	8,391	N/A	20,875	N/A
12/31/2017	153,236	7,467	N/A	25,206	N/A
9/30/2017	156,370	10,604	N/A	26,466	N/A
6/30/2017	151,796	8,908	N/A	22,206	N/A
3/31/2017	155,601	6,367	N/A	14,905	N/A
12/31/2016	156,295	5,467	N/A	2,831	N/A
9/30/2016	156,210	2,276	N/A	2,211	N/A
6/30/2016	155,744	5,008	N/A	5,469	N/A
3/31/2016	146,009	6,552	N/A	3,341	N/A
12/31/2015	143,740	7,858	N/A	9,152	N/A
9/30/2015	140,486	6,813	N/A	8,574	N/A
6/30/2015	136,963	4,968	N/A	8,418	N/A
3/31/2015	134,078	3,448	N/A	11,176	N/A
12/31/2014	128,383	4,048	N/A	9,632	N/A
9/30/2014	130,208	7,120	N/A	7,711	N/A
6/30/2014	126,332	7,195	N/A	7,430	N/A
3/31/2014	115,739	7,517	N/A	12,185	N/A
12/31/2013	107,812	6,979	N/A	13,548	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: A089980's forecast earnings growth (39.4% per year) is above the savings rate (2.6%).

Winst versus markt: A089980's earnings (39.4% per year) are forecast to grow faster than the KR market (29.7% per year).

Hoge groeiwinsten: A089980's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: A089980's revenue (20.3% per year) is forecast to grow faster than the KR market (10.5% per year).

Hoge groei-inkomsten: A089980's revenue (20.3% per year) is forecast to grow faster than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: A089980's Return on Equity is forecast to be low in 3 years time (8.6%).

Sang-A FrontecLtd Toekomstige groei

Future criteriumcontroles 5/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus EPS estimates fall by 12%

Price target increased to ₩100,000

Consensus EPS estimates fall to ₩735

Recent updates

Consensus EPS estimates fall by 12%

Is Sang-A FrontecLtd (KOSDAQ:089980) Using Too Much Debt?

With A 25% Price Drop For Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) You'll Still Get What You Pay For

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 15%

New minor risk - Share price stability

Investors Could Be Concerned With Sang-A FrontecLtd's (KOSDAQ:089980) Returns On Capital

Investor sentiment improves as stock rises 15%

Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) 26% Share Price Surge Not Quite Adding Up

Is It Time To Consider Buying Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)?

We Think Sang-A FrontecLtd (KOSDAQ:089980) Is Taking Some Risk With Its Debt

Investor sentiment improves as stock rises 15%

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of ₩200 per share at 1.0% yield

New minor risk - Profit margin trend

Sang-A Frontec Co.,Ltd. announced that it has received KRW 60 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Mirae Asset Securities Co. Ltd., Samsung Securities Co., Ltd.

Sang-A Frontec Co.,Ltd. announced that it expects to receive KRW 60 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, NH Investment & Securities Co., Ltd., KB Securities Co., Ltd., Mirae Asset Securities Co. Ltd., Samsung Securities Co., Ltd. and other investors

Full year 2022 earnings released: EPS: ₩476 (vs ₩608 in FY 2021)

Upcoming dividend of ₩200 per share

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Price target increased to ₩100,000

Upcoming dividend of ₩160 per share

Consensus EPS estimates fall to ₩735

First quarter 2021 earnings released: EPS ₩145 (vs ₩148 in 1Q 2020)

Sang-A Frontec Co.,Ltd. announced that it has received KRW 31.051261 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, SK Securities Co., Ltd., Investment Arm

Sang-A Frontec Co.,Ltd. announced that it expects to receive KRW 31.051261 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, SK Securities Co., Ltd., Investment Arm

Returns On Capital Signal Tricky Times Ahead For Sang-A FrontecLtd (KOSDAQ:089980)

Full year 2020 earnings released: EPS ₩153 (vs ₩842 in FY 2019)

Estimating The Intrinsic Value Of Sang-A Frontec Co.,Ltd. (KOSDAQ:089980)

Sang-A Frontec Co.,Ltd., Annual General Meeting, Mar 23, 2021

These 4 Measures Indicate That Sang-A FrontecLtd (KOSDAQ:089980) Is Using Debt Extensively

New 90-day high: ₩59,400

Is Sang-A Frontec Co.,Ltd. (KOSDAQ:089980) Potentially Undervalued?

New 90-day high: ₩50,300

Shareholders Of Sang-A FrontecLtd (KOSDAQ:089980) Must Be Happy With Their 286% Total Return

What Type Of Shareholders Make Up Sang-A Frontec Co.,Ltd.'s (KOSDAQ:089980) Share Registry?

New 90-day high: ₩48,000

Should We Be Excited About The Trends Of Returns At Sang-A FrontecLtd (KOSDAQ:089980)?

New 90-day low: ₩36,300

Sang-A Frontec Co.,Ltd. announced that it has received KRW 30 billion in funding from SK Securities Co., Ltd., Investment Arm

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven